Pennanen, Heli <br/><br/>
Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.  [electronic resource] 

 -  European journal of haematology  Oct 2008 
 - 289-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2008.01113.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Leukemic<br/>Humans<br/>Immunochemistry<br/>Lymph Nodes--metabolism<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Middle Aged<br/>Predictive Value of Tests<br/>Retrospective Studies<br/>Survival Rate<br/>Tissue Inhibitor of Metalloproteinase-1--biosynthesis<br/>Tissue Inhibitor of Metalloproteinase-2--biosynthesis<br/>Tumor Suppressor Protein p53--biosynthesis